These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21419112)

  • 1. Complement C3 and cleavage products in cardiometabolic risk.
    Onat A; Can G; Rezvani R; Cianflone K
    Clin Chim Acta; 2011 Jun; 412(13-14):1171-9. PubMed ID: 21419112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Major influence of dysfunctions of protective serum proteins on cardiometabolic risk among Turks and gender difference].
    Onat A; Hergenç G; Can G
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):425-34. PubMed ID: 20019460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study).
    van Greevenbroek MM; Jacobs M; van der Kallen CJ; Blaak EE; Jansen EH; Schalkwijk CG; Feskens EJ; Stehouwer CD
    Int J Cardiol; 2012 Jan; 154(2):158-62. PubMed ID: 20926148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence.
    Ursini F; Abenavoli L
    Rev Recent Clin Trials; 2018 Jan; 13(1):61-68. PubMed ID: 29189176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of high-density lipoprotein and its apolipoproteins: new mechanisms underlying cardiometabolic risk in the population at large.
    Onat A; Can G; Yüksel H
    Turk Kardiyol Dern Ars; 2012 Jun; 40(4):368-85. PubMed ID: 22951857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
    Muscari A; Massarelli G; Bastagli L; Poggiopollini G; Tomassetti V; Drago G; Martignani C; Pacilli P; Boni P; Puddu P
    Eur Heart J; 2000 Jul; 21(13):1081-90. PubMed ID: 10843826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
    Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
    Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
    Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.